Last reviewed · How we verify
Risperidone Orally Disintegrating Tablets
At a glance
| Generic name | Risperidone Orally Disintegrating Tablets |
|---|---|
| Also known as | (Risperdal M-TAB) tablets of Janssen Pharmaceutica Products |
| Sponsor | Dr. Reddy's Laboratories Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions (NA)
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions (NA)
- Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions (PHASE1)
- Bioavailability Study of Risperidone Orally Disintegrating Tablets 1 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions (PHASE1)
- Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |